BCL2 and chronic myelogenous leukemia, BCR-ABL1 positive: We observed a significant inhibition in the expression pro-survival Bcl2 gene transcripts by the ECM compared to media, and this decrease was attenuated with CML modification of the ECM (Figure 5A).